Projecten per jaar
Persoonlijk profiel
Expertise
- Basic and translational research in multiple myeloma
- Research for therapies, targeting the myeloma cell in its microenvironment
- Study of functional interaction between the cancer cell and its microenvironment using microarray, realtime PCR and FACS analysis and westernblotting.
- Investigate the influence of histon deacetylase inhibitors (HDAC-I) in 5TMM models.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Karin Vanderkerken actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
FWOAL1045: Gepersonaliseerde therapie gericht tegen het AXL eiwit voor de behandeling van acute myeloide leukemie en multipel myeloom
De Veirman, K., Devoogdt, N. & Vanderkerken, K.
1/01/22 → 31/12/25
Project: Fundamenteel
-
EU639: EUTOPIA - Transformatie van onderzoek en innovatie (TRAIN)
1/01/21 → 31/12/23
Project: Fundamenteel
-
OZR3286: Bilateral cooperation within the framework of a joint doctoral project: Bench Fee for Joint PhD VUB-UGent, Vlummens Philip
13/02/18 → 31/12/22
Project: Fundamenteel
-
SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Thielemans, K., Vanderkerken, K. & Breckpot, K.
1/11/17 → 31/10/22
Project: Fundamenteel
-
AIIFUND22: Een nieuwe strategie in het uitroeien van residuele kankercellen in multipel myeloom.
Vanderkerken, K. & De Veirman, K.
28/09/17 → …
Project: Fundamenteel
Onderzoeksoutput
-
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
Verheye, E., Melgar, J. B., Deschoemaeker, S., Raes, G., Maes, A., De Bruyne, E., Menu, E., Vanderkerken, K., Laoui, D. & De Veirman, K., 14 jan 2022, In : International Journal of Molecular Sciences. 23, 2, 904.Onderzoeksoutput: Scientific review
Open Access1 Citaat (Scopus) -
Exosomes in Multiple Myeloma: from bench to bedside
Menu, E. & Vanderkerken, K., 2022, In : Blood.Onderzoeksoutput: Article
Open Access -
Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma
De Beck, L., Awad, R. M., Basso, V., Casares, N., De Ridder, K., De Vlaeminck, Y., Gnata, A., Goyvaerts, C., Lecocq, Q., San José-Enériz, E., Verhulst, S., Maes, K., Vanderkerken, K., Agirre, X., Prosper, F., Lasarte, J. J., Mondino, A. & Breckpot, K., 2022, In : Frontiers in Immunology. 13, 15 blz., 799636.Onderzoeksoutput: Article
Open Access -
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach
Vlummens, P., Verhulst, S., De Veirman, K., Maes, A., Menu, E., Moreaux, J., De Bruyne, E., Hose, D., Vanderkerken, K. & Maes, K., 8 jun 2022, In : Frontiers in cell and developmental biology. 10, 879057.Onderzoeksoutput: Article
Open Access -
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
Oudaert, I., Satilmis, H., Vlummens, P., De Brouwer, W., Maes, A., Hose, D., De Bruyne, E., Ghesquière, B., Vanderkerken, K., De Veirman, K. & Menu, E., 1 feb 2022, In : Journal of Experimental & Clinical Cancer Research. 41, 1, blz. 45 17 blz., 45.Onderzoeksoutput: Article
Open Access
Prijzen
-
Award of the Association for International Cancer Research
Karin Vanderkerken (Recipient), 2004
Prijs: Prize (including medals and awards)
-
Hilde Bruers Award
Karin Vanderkerken (Recipient), 29 feb 2008
Prijs: Prize (including medals and awards)
-
Junior Award Multiple Myeloma Research Foundation
Karin Vanderkerken (Recipient), 2001
Prijs: Prize (including medals and awards)
-
Laureaat Belgische Federatie tegen Kanker
Karin Vanderkerken (Recipient), 2001
Prijs: Prize (including medals and awards)
-
Laureaat Belgische Federatie tegen Kanker
Karin Vanderkerken (Recipient), 2004
Prijs: Prize (including medals and awards)
Activiteiten
-
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
Lien De Beck (Speaker), Robin Maximilian Awad (Contributor), Yannick De Vlaeminck (Contributor), Veronica Basso (Contributor), Noelia Casares (Contributor), Stefaan Verhulst (Contributor), Edurne San José-Enériz (Contributor), Kirsten De Ridder (Contributor), Cleo Goyvaerts (Contributor), Ken Maes (Contributor), Karin Vanderkerken (Contributor), Xabier Agirre (Contributor), Filipe Prosper (Contributor), Juan José Lasarte (Contributor), Anna Mondino (Contributor), Karine Breckpot (Contributor)11 feb 2021Activiteit: Talk or presentation at a conference
-
MCL1 Inhibitors in Multiple Myeloma
Kim De Veirman (Contributor), Karin Vanderkerken (Speaker), Elke De Bruyne (Contributor), Eline Menu (Contributor)13 nov 2019Activiteit: Talk or presentation at a conference
-
Lunchdebat Gelijkheidsactieplan
Gina Rossi (Participant), Karin Vanderkerken (Participant)19 nov 2019Activiteit: Other
-
Epigen meeting
Karin Vanderkerken (Participant)27 feb 2014Activiteit: Participation in workshop, seminar
-
28th General Annual Meeting of the Belgian Hematological Society
Karin Vanderkerken (Participant)24 jan 2013 → 26 jan 2013Activiteit: Participation in conference
Knipsels
Scriptie
-
Anti-myeloom effect van histon deacetylase inhbitor LBH589 op het 5T33MM muismodel
Auteur: Lemaire, M., Vanderkerken, K. & Deleu, S., 1 jul 2007Begeleider: Vanderkerken, K. (Promotor) & Deleu, S. (Co-promotor)
Scriptie/masterproef: Master's Thesis
-
ASPIRE: adjuvant-driven induction of cancer Specific Immune Responses
Auteur: Van Der Jeught, K., Breckpot, K., Thielemans, K., Vanderkerken, K., Menu, E., van Grunsven, L. A., Pascolo, S. & Raemdonck, K., 20 okt 2016Begeleider: Breckpot, K. (Promotor), Thielemans, K. (Promotor), Vanderkerken, K. (Jury), Van Grunsven, L. A. (Jury), Menu, E. (Jury), Van Raemdonck, K. (Externe persoon) (Jury) & Pascolo, S. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Beta cell regeneration and normoglycemia restoration in diabetic mica through myeloid cell-driven angiogenesis
Auteur: Xiao, X., 6 jun 2011Begeleider: Heimberg, H. (Promotor), Dor, Y. (Externe persoon) (Jury), Haigh, J. (Externe persoon) (Jury), Luttun, A. (Externe persoon) (Jury), Vanderkerken, K. (Jury), Tournaye, H. (Jury), Van Riet, I. (Promotor) & Thielemans, K. (Promotor)
Scriptie/masterproef: Doctoral Thesis
-
Beta cell regeneration and normoglycemia restoration in diabetic mice through myeloid celldriven angiogenesis
Auteur: Xiao, X., Heimberg, H., Thielemans, K., Vanderkerken, K., Tournaye, H., Van Riet, I., Dor, Y., Haigh, J. & Luttun, A., 6 jun 2011Begeleider: Heimberg, H. (Promotor), Thielemans, K. (Jury), Vanderkerken, K. (Jury), Tournaye, H. (Jury), Van Riet, I. (Jury), Dor, Y. (Externe persoon) (Jury), Haigh, J. (Externe persoon) (Jury) & Luttun, A. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
Biological and clinical implications of invariant natural killer T cells in multiple myeloma: rising the potential for immunotherapy
Auteur: Nur, H., Menu, E. & Vanderkerken, K., 17 sep 2014Begeleider: Menu, E. (Promotor) & Vanderkerken, K. (Promotor)
Scriptie/masterproef: Doctoral Thesis